Key Record Dates
ClinicalTrials.gov Identifier: | NCT03656536 |
---|---|
Brief Title: | A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma (FIGHT-302) |
First Submitted : | August 29, 2018 |
First Submitted that Met QC Criteria : | August 30, 2018 |
First Posted : | September 4, 2018 |
Last Update Submitted that Met QC Criteria : | April 9, 2024 |
Last Update Posted : | April 10, 2024 |